It seems those who know better are thinking differently to the retail day-traders who panicked!
I like this bit that reflects what I had anticipated to be the case, that further analysis of data (good or average results in subgroups) will shine light on how application/technique can be improved:
"The [subgroup] data allows us to more specifically address certain meaningful patient populations and maximize the chance of a benefit for those patient groups. "
... which may answer your question @ML173.
Ann: EOC Pharma confirms plans to advance Efti in China for MBC, page-3
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |